• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国帕金森病死亡率:上海十年随访研究结果。

Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.

机构信息

Department of Neurology and Neuroscience Institute, Ruijin Hospital affiliated to Shanghai, Jiao Tong University School of Medicine, Shanghai, 200025, China.

Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.

出版信息

Parkinsonism Relat Disord. 2018 Oct;55:75-80. doi: 10.1016/j.parkreldis.2018.05.012. Epub 2018 May 23.

DOI:10.1016/j.parkreldis.2018.05.012
PMID:29802079
Abstract

BACKGROUND

Standardized mortality ratio (SMR) is the most frequently used index in Parkinson's disease (PD) survival survey. However, there is little SMR data in PD from China.

OBJECTIVE: To examine the outcome, including overall and cause-specific mortality, of PD patients subsequent to 10 years of surveillance in Shanghai, China. This is an extension study of our previous investigation on mortality.
 METHODS: One hundred fifty-seven PD patients recruited from the movement disorder clinic of Rui Jin Hospital in 2006 were followed up until December 31, 2016 or death, representing a follow-up period of up to 10 years. Overall and cause-specific standardized mortality ratios (SMR) were calculated, and predictors for survival at disease onset were estimated.
 RESULTS: Thirty one patients had died by December 31, 2016, and the SMR at 10 years of follow-up was 0.87 (0.59-1.25). The primary direct cause of death was respiratory disease (SMR = 3.52, 95% CI 1.98-5.78). Employing Cox's proportional hazard modeling, postural instability gait disorder (PIGD) type and older age at onset predicted poor survival in this cohort.

CONCLUSIONS

This finding confirms the similar survival of patients with PD to the control population in the post-levodopa era. PIGD type and older age at onset had a negative impact on survival.

摘要

背景

标准化死亡率(SMR)是帕金森病(PD)生存调查中最常用的指标。然而,中国 PD 的 SMR 数据很少。

目的

检查中国上海 PD 患者 10 年监测后的结果,包括总死亡率和特定原因死亡率。这是我们之前关于死亡率调查的扩展研究。

方法

2006 年从瑞金医院运动障碍诊所招募了 157 名 PD 患者,随访至 2016 年 12 月 31 日或死亡,随访时间最长可达 10 年。计算了总死亡率和特定原因标准化死亡率(SMR),并估计了发病时生存的预测因素。

结果

截至 2016 年 12 月 31 日,31 名患者死亡,10 年随访的 SMR 为 0.87(0.59-1.25)。主要直接死因是呼吸系统疾病(SMR=3.52,95%CI 1.98-5.78)。采用 Cox 比例风险模型,姿势不稳步态障碍(PIGD)型和发病年龄较大预测了该队列的不良生存。

结论

这一发现证实了在左旋多巴治疗后时代,PD 患者的生存与对照人群相似。PIGD 型和发病年龄较大对生存有负面影响。

相似文献

1
Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.中国帕金森病死亡率:上海十年随访研究结果。
Parkinsonism Relat Disord. 2018 Oct;55:75-80. doi: 10.1016/j.parkreldis.2018.05.012. Epub 2018 May 23.
2
Mortality in Parkinson's disease: a 38-year follow-up study.帕金森病的死亡率:一项 38 年的随访研究。
Mov Disord. 2015 Feb;30(2):266-9. doi: 10.1002/mds.26060. Epub 2014 Dec 1.
3
Mortality from Parkinson's disease in China: Findings from a five-year follow up study in Shanghai.中国帕金森病死亡率:上海一项为期五年的随访研究结果
Can J Neurol Sci. 2015 Jul;42(4):242-7. doi: 10.1017/cjn.2015.49.
4
Survival in patients with Parkinson's disease: a ten-year follow-up study in northern China.帕金森病患者的生存状况:中国北方地区的十年随访研究。
BMC Neurol. 2022 Sep 22;22(1):367. doi: 10.1186/s12883-022-02899-5.
5
Mortality of Alzheimer's Disease Patients: A 10-Year Follow-up Pilot Study in Shanghai.阿尔茨海默病患者死亡率:上海 10 年随访试点研究。
Can J Neurol Sci. 2020 Mar;47(2):226-230. doi: 10.1017/cjn.2019.333.
6
Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients.十年随访:中国帕金森病患者的生存和结局分析
J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):607-11. doi: 10.1136/jnnp-2011-301590. Epub 2012 Feb 22.
7
The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study.年龄对帕金森病生存的修饰作用:一项基于人群的队列研究。
Neuroepidemiology. 2019;53(1-2):13-19. doi: 10.1159/000492672. Epub 2019 Jun 14.
8
Mortality in Parkinson's disease: a 20-year follow-up study.帕金森病的死亡率:一项20年的随访研究。
Mov Disord. 2009 Apr 30;24(6):819-25. doi: 10.1002/mds.22414.
9
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.悉尼帕金森病多中心研究:10年病程及死亡率
J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):300-7. doi: 10.1136/jnnp.67.3.300.
10
The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up).塞戈维亚省帕金森病的自然史:一项纵向研究(20 年随访)中的死亡率。
Acta Neurol Scand. 2013 May;127(5):295-300. doi: 10.1111/ane.12003. Epub 2012 Sep 7.

引用本文的文献

1
Prediction of all-cause mortality in Parkinson's disease with explainable artificial intelligence using administrative healthcare data.利用行政医疗保健数据,通过可解释人工智能预测帕金森病的全因死亡率。
NPJ Parkinsons Dis. 2025 Jun 2;11(1):144. doi: 10.1038/s41531-025-01007-x.
2
All-Cause and Cause-Specific Mortality in Parkinson's Disease: A Meta-Analysis.帕金森病的全因死亡率和特定病因死亡率:一项荟萃分析。
Neuroepidemiology. 2025 Apr 29:1-12. doi: 10.1159/000546136.
3
Use and misuse of domperidone in patients living with Parkinson disease in France.
法国帕金森病患者中多潘立酮的使用与误用情况
Fundam Clin Pharmacol. 2025 Apr;39(2):e70002. doi: 10.1111/fcp.70002.
4
Seasonality as a risk factor for deaths in Parkinson's disease.季节变化作为帕金森病死亡的一个风险因素。
Clinics (Sao Paulo). 2024 Oct 25;79:100506. doi: 10.1016/j.clinsp.2024.100506. eCollection 2024.
5
Association of health behaviors with function and health-related quality of life among patients with Parkinson's disease.帕金森病患者健康行为与功能及健康相关生活质量的关系。
Isr J Health Policy Res. 2024 Jan 3;13(1):2. doi: 10.1186/s13584-023-00588-3.
6
Oscillometry of the respiratory system in Parkinson's disease: physiological changes and diagnostic use.呼吸系统在帕金森病中的容积描记法:生理变化及诊断用途。
BMC Pulm Med. 2023 Oct 26;23(1):406. doi: 10.1186/s12890-023-02716-w.
7
Socio-Clinical factors associated with Parkinson's disease-related specific self-management behaviours.与帕金森病相关特定自我管理行为相关的社会临床因素。
Chronic Illn. 2024 Dec;20(4):699-711. doi: 10.1177/17423953231198893. Epub 2023 Sep 6.
8
Mortality of Deep Brain Stimulation and Risk Factors in Patients With Parkinson's Disease: A National Cohort Study in Korea.深部脑刺激治疗帕金森病患者的死亡率和危险因素:韩国全国队列研究。
J Korean Med Sci. 2023 Jan 16;38(3):e10. doi: 10.3346/jkms.2023.38.e10.
9
Pulmonary function and medication effect in mild-stage subjects with Parkinson's disease.轻度帕金森病患者的肺功能和药物疗效。
Arq Neuropsiquiatr. 2022 Dec;80(12):1233-1238. doi: 10.1055/s-0042-1758753. Epub 2022 Dec 29.
10
Survival in patients with Parkinson's disease: a ten-year follow-up study in northern China.帕金森病患者的生存状况:中国北方地区的十年随访研究。
BMC Neurol. 2022 Sep 22;22(1):367. doi: 10.1186/s12883-022-02899-5.